About NI-ADAPT

The Northern Ireland Advanced Drug and Pharmaceutical Translation Programme is a Medical Research Council Doctoral Landscape Award led by Queen’s University Belfast School of Pharmacy in partnership with Ulster University.

NI-ADAPT will train PhD researchers, with the first students joining the four-year programme in October 2027.

NI-ADAPT will equip researchers to bridge a critical gap between scientific discovery and clinical application. Students will combine disease biology and pharmaceutical science with artificial intelligence, advanced drug delivery, data analytics, regulation and commercialisation, preparing them to work across research, healthcare and industry.

Their research will target four major areas of unmet health need: cancer, infection and antimicrobial resistance, lung disease and vision loss. Students will also have the opportunity to undertake placements with our external partners, and engage with patient groups, gaining direct experience of translating laboratory discoveries into practical solutions.

The programme will connect Northern Ireland’s academic expertise with major regional investments and draw on a network of more than 30 industry, clinical, charitable, patient group and innovation partners.

By developing scientists with advanced digital, translational and commercial skills, NI-ADAPT will address critical workforce shortages, strengthen productivity and help Northern Ireland attract further life-sciences investment. The programme will support the UK Life Sciences Sector Plan by creating the talent needed to move promising discoveries more rapidly towards new treatments, technologies and businesses.

Research themes

Students will be recruited to one of three research theme areas

Drug Repurposing, AI Tools & Mechanistic Validation

PhD projects coming soon

Mucosal Delivery & Barrier Biology

PhD projects coming soon

Advanced Therapeutics & Host Response

PhD projects coming soon

Disease areas

The themes tackle disease areas of focus, so projects will be offered to address issues in the disease areas of:

  • Cancer
  • Infection & antimicrobial resistance
  • Lung disease
  • Vision loss

Apply to NI-ADAPT

NI-ADAPT will open for applications December 2026, with the first cohort of students commencing in October 2027.

Find out how to apply